Abstract
Soluble components of type 8 adenovirus have been studied. Four different components were isolated by anion-exchange chromatography and purified by further chromatographic procedures, by zonal centrifugation, and by erythrocyte absorption and elution. The four components exhibited the following characteristics. (i) Fiber antigen was trypsin-resistant and functioned as incomplete hemagglutinin (agglutinated rat and human erythrocytes only in the presence of certain types of adenovirus antisera). (ii) The penton was trypsin-sensitive, exerted a cytotoxic effect, and also showed incomplete hemagglutination, being active in the presence of a majority of heterotypic adenovirus antisera studied. (iii) The group-specific hexon antigen reacted in complement fixation reaction and gel precipitation with sera prepared against other types of adenoviruses, besides showing characteristics indicating the presence of a type-specific antigen component. (iv) The soluble complete hemagglutinin was trypsin-sensitive, displayed cytotoxic effect, adsorbed easily to human and rat erythrocytes, and could be eluted from them by means of receptor-destroying enzyme. The three hemagglutinins of adenovirus type 8 proved to be highly unstable, and their demonstration was only successful by using a large quantity of freshly prepared concentrated virus material. Considering these conditions, a method was developed for their concentration and purification.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BELADI I., KAHAN A., KUKAN E., MUCSI I., PAPAI I. AETIOLOGIC RELATIONSHIP OF ADENOVIRUS TYPE 8 TO THE EPIDEMIC OF KERATOCONJUNCTIVITIS IN SZEGED. Acta Microbiol Acad Sci Hung. 1963;10:59–63. [PubMed] [Google Scholar]
- Bauer W., Wigand R. Vergleichende Untersuchungen an Hämagglutininen von Adenovirusstämmen der Gruppen I und II. Arch Gesamte Virusforsch. 1967;21(1):11–24. [PubMed] [Google Scholar]
- Döhner L. Untersuchungen zum Nachweis von serologischen Unterschieden zwischen den Gruppenantigenen aus verschiedenen Adenovirustypen. I. Herstellung von Adenovirusgruppenantigenen. Z Immunitatsforsch Allerg Klin Immunol. 1968 Nov;136(4):404–414. [PubMed] [Google Scholar]
- Gelderblom H., Bauer H., Frank H., Wigand R. The structure of group II adenoviruses. J Gen Virol. 1967 Oct;1(4):553–560. doi: 10.1099/0022-1317-1-4-553. [DOI] [PubMed] [Google Scholar]
- Gelderblom H., Meiser W., Lengyel A., Wigand R. The serological relationship of the soluble antigens of adenovirus type 19. J Gen Virol. 1968 May;2(3):331–340. doi: 10.1099/0022-1317-2-3-331. [DOI] [PubMed] [Google Scholar]
- HARUNA I., YAOI H., KONO R., WATANABE I. Separation of adenovirus by chromatography on DEAE-Cellulose. Virology. 1961 Feb;13:264–267. doi: 10.1016/0042-6822(61)90065-4. [DOI] [PubMed] [Google Scholar]
- JAWETZ E., KIMURA S. J., HANNA L., COLEMAN V. R., THYGESON P., NICHOLAS A. Studies on the etiology of epidemic keratoconjunctivitis. Am J Ophthalmol. 1955 Nov;40(5 Pt 2):200-9; discussion, 209-11. doi: 10.1016/0002-9394(55)91856-0. [DOI] [PubMed] [Google Scholar]
- KASEL J. A., ROWE W. P., NEMES J. L. Modification of erythrocyte receptors by a factor in adenovirus suspensions. Virology. 1960 Mar;10:388–391. doi: 10.1016/0042-6822(60)90035-0. [DOI] [PubMed] [Google Scholar]
- KJELLEN L. A study of adenovirus-host cell system by the plaque technique. Virology. 1961 Jun;14:234–239. doi: 10.1016/0042-6822(61)90198-2. [DOI] [PubMed] [Google Scholar]
- Kjellén L., Pereira H. G. Role of adenovirus antigens in the induction of virus neutralizing antibody. J Gen Virol. 1968 Jan;2(1):177–185. doi: 10.1099/0022-1317-2-1-177. [DOI] [PubMed] [Google Scholar]
- LENGYEL A., NASZ I. ADENOVIRUS HAEMAGGLUTINATION-INHIBITING ANTIBODIES IN HUMAN SERA. Acta Microbiol Acad Sci Hung. 1964;11:105–113. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lengyel A., Dán P., Cserba I., Nász I. Die wechselseitige heterotypische Hämmagglutinations-Hemmungsreaktion mit Adenoviren Typ 8, 9 und 10. Z Immunitatsforsch Allerg Klin Immunol. 1965 Jul;129(1):34–41. [PubMed] [Google Scholar]
- Levine A. J., Ginsberg H. S. Role of adenovirus structural proteins in the cessation of host-cell biosynthetic functions. J Virol. 1968 May;2(5):430–439. doi: 10.1128/jvi.2.5.430-439.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NASZ I., KULCSAR G., DAN P., LENGYEL A., CSERBA I. STUDIES ON THE AETIOLOGY OF EPIDEMIC KERATOCONJUNCTIVITIS OBSERVED IN BUDAPEST DURING WINTER, 1961--1962. Acta Microbiol Acad Sci Hung. 1963;10:35–40. [PubMed] [Google Scholar]
- NASZ I., LENGYEL A., DAN P., KULCSAR G. HETEROTYPIC HAEMAGGLUTINATION INHIBITION IN THE ADENOVIRUS GROUP. Acta Microbiol Acad Sci Hung. 1963;10:379–385. [PubMed] [Google Scholar]
- NASZ I. SOME BIOLOGICAL CHARACTERISTICS OF ADENOVIRUS TYPE 8 STRAINS. Acta Microbiol Acad Sci Hung. 1963;10:355–363. [PubMed] [Google Scholar]
- Norby E. Comparative studies on the soluble components of adenovirus types 9 and 15 and the intermediate strain 9-15. J Virol. 1968 Oct;2(10):1200–1210. doi: 10.1128/jvi.2.10.1200-1210.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norrby E. Biological significance of structural adenovirus components. Curr Top Microbiol Immunol. 1968;43:1–43. doi: 10.1007/978-3-642-46118-7_1. [DOI] [PubMed] [Google Scholar]
- Norrby E. Identification of soluble components of adenovirus type 11. J Gen Virol. 1968 Jan;2(1):123–133. doi: 10.1099/0022-1317-2-1-123. [DOI] [PubMed] [Google Scholar]
- Norrby E., Skaaret P. Comparison between soluble components of adenovirus types 3 and 16 and of the intermediate strain 3-16 (the San Carlos agent). Virology. 1968 Oct;36(2):201–211. doi: 10.1016/0042-6822(68)90137-2. [DOI] [PubMed] [Google Scholar]
- Norrby E. The structural and functional diversity of Adenovirus capsid components. J Gen Virol. 1969 Sep;5(2):221–236. doi: 10.1099/0022-1317-5-2-221. [DOI] [PubMed] [Google Scholar]
- PEREIRA H. G., DE FIGUEIREDO M. V. Mechanism of hemagglutination by adenovirus types 1,2,4,5 and 6. Virology. 1962 Sep;18:1–8. doi: 10.1016/0042-6822(62)90171-x. [DOI] [PubMed] [Google Scholar]
- PEREIRA H. G. Typing of adenoidal-pharyngeal-conjunctival (APC) viruses by complement-fixation. J Pathol Bacteriol. 1956 Jul;72(1):105–109. [PubMed] [Google Scholar]
- Pettersson U., Philipson L., Höglund S. Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen. Virology. 1967 Dec;33(4):575–590. doi: 10.1016/0042-6822(67)90057-8. [DOI] [PubMed] [Google Scholar]
- Piña M., Green M. Biochemical studies on adenovirus multiplication. IX. Chemical and base composition analysis of 28 human adenoviruses. Proc Natl Acad Sci U S A. 1965 Aug;54(2):547–551. doi: 10.1073/pnas.54.2.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pusztai R., Béládi I., Bakay M., Mucsi I. Effect of ultraviolet irradiation and heating on the interferon-inducing capacity of human adenoviruses. J Gen Virol. 1969 Mar;4(2):169–176. doi: 10.1099/0022-1317-4-2-169. [DOI] [PubMed] [Google Scholar]
- ROSEN L. A hemagglutination-inhibition technique for typing adenoviruses. Am J Hyg. 1960 Jan;71:120–128. doi: 10.1093/oxfordjournals.aje.a120085. [DOI] [PubMed] [Google Scholar]
- TAKATSY G. The use of spiral loops in serological and virological micro-methods. Acta Microbiol Acad Sci Hung. 1955;3(1-2):191–202. [PubMed] [Google Scholar]
- Trentin J. J., Van Hoosier G. L., Jr, Samper L. The oncogenicity of human adenoviruses in hamsters. Proc Soc Exp Biol Med. 1968 Mar;127(3):683–689. doi: 10.3181/00379727-127-32773. [DOI] [PubMed] [Google Scholar]
- Valentine R. C., Pereira H. G. Antigens and structure of the adenovirus. J Mol Biol. 1965 Aug;13(1):13–20. doi: 10.1016/s0022-2836(65)80076-6. [DOI] [PubMed] [Google Scholar]
- WILCOX W. C., GINSBERG H. S. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS. Proc Soc Exp Biol Med. 1963 Oct;114:37–42. doi: 10.3181/00379727-114-28579. [DOI] [PubMed] [Google Scholar]
